FEATURE ARTICLES

Screening for Down’s syndrome is an important part of antenatal care, and ideally should be undertaken within the first three months of the pregnancy. Assay combinations now offer a means to achieve this aim.

Methotrexate, a toxic chemotherapeutic agent used to treat various conditions, requires close laboratory monitoring. Here, Rick Allan and Kevin Sensier describe their evaluation of two assays.

Much has changed in coagulation testing over the past several decades but the partnership that has developed between Glan Clywd Hospital in North Wales and Sysmex continues provide satisfaction.

Siemens Healthcare Diagnostics recently held two user meetings, one to consider the latest in pathology service configuration efficiency, and the other to address the latest developments in point-of-care testing

Effective and efficient management of point-of-care testing across a large hospital trust requires a dedicated team and the latest technology, as this overview of the situation in Cambridge illustrates.

The experiences of two large hospital trusts demonstrate the advantages of working with Sysmex UK and using the company’s range of fully automated haematology and coagulation solutions.

The two-day VBMPS congress, to be held at the International Convention Centre in Birmingham on 15-16 October, aims to highlight the link between human and animal health, focusing on the study, diagnosis and treatment of animal diseases. Concurrent sessions will be held in Cellular Pathology, Haematology/Clinical Chemistry, Microbiology/Infection and Pharma Science, and delegates may attend any presentation in any of the streams

As human papillomavirus testing is rolled out on the NHS Cervical Screening Programme in England for use at triage, Tracy Huggins examines its benefits and its potential as a future primary screening technique.

The NHS Cervical Screening Programme is reaping the benefits of automation through the use of liquid-based techniques and automated technology, as Wilma Anderson explains.

An individual’s phenotype can be influenced by their lifestyle, and this can determine how they respond to drugs and other treatments. Now, a legacy of the London Games aims to investigate the human phenome on an unprecedented scale.

In order to transform haematology services at Kingston Hospital, a partnership forged with Beckman Coulter has facilitated staff retraining, the updating of IT systems and the installation of state-of-the art analysis systems.

Automation is forging ahead in microbiology and is being helped by the application of liquid-based technologies and the latest developments in the design of the humble yet ubiquitous swab. Here, Rachel Adams takes a look at the latest innovations.

Tendering for, and implementing, new laboratory equipment can be a fraught process, but the partnership approach adopted by Ipswich Hospital NHS Trust and Sysmex ensured a positive outcome.

Flow cytometry has found application in cell analysis across a wide range of scientific fields. Now, small-footprint, easy-to-use instruments are able to offer the very highest levels of performance, as Danny Köhler explains.

Requests for vitamin D testing are on the increase and three laboratories, in Coventry, Kingston and central London, are reaping the benefits of using an Elecsys assay from Roche. Dawn Wallace reports.

Adoption of the Uri semi-automated urine analysis system from Mast has reduced turnaround times and increased staff productivity in microbiology, as Chris Baker explains.

Successful bone sectioning requires a combination of skill born of experience, and the right equipment. In the latter regard, Thermo Scientific’s range of automated microtomes fit the bill.

A unit at the forefront of immunohistochemistry and molecular diagnostics for over 30 years has adopted an innovative companion diagnostic testing platform for its cancer diagnostic programme. UCL Advanced Diagnostics (UCL-AD) has chosen Roche’s HER2 assays on the BenchMark Ultra staining platform to advance its programme of companion diagnostics for cancer patients.

Europe’s microbiologists were able to take an early look at Beckman Coulter’s new random-access system for molecular diagnostics at the recent ECCMID meeting held in London. Here, Leanne Annereau answers some of the questions that delegates may not have had the chance to pose.

Following the establishment of an internal life science quality control laboratory and recruitment of experienced histologists, Atom Scientific’s commitment to providing market-leading quality has taken a significant step forward. Since January 2011, Atom Scientific has been undertaking a significant investment programme in all elements of the company’s infrastructure, with a specific focus on product quality.